天眼查App显示，近日，合肥市美加特气体有限公司成立，法定代表人为邵晓军，注册资本100万人民 币，经营范围为一般项目：销售代理；租赁服务（不含许可类租赁服务）；特种设备销售；特种设备出 租；食品添加剂销售；专用化学产品销售（不含危险化学品）；阀门和旋塞销售；金属结构销售；五金 产品零售；技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；劳务服务（不含劳务派 遣）；运输设备租赁服务；通用设备修理（除许可业务外，可自主依法经营法律法规非禁止或限制的项 目）。 ...

Group 1 - A new company, Ganzhou Shun'an Chemical Co., Ltd., has been established with a registered capital of 5 million RMB [1] - The legal representative of the company is Guo Jinlan [1] - The company's business scope includes the sale of various chemical products, agricultural products, and metal materials, among others [1] Group 2 - The company is involved in the sales of non-hazardous chemical products, disinfectants, fertilizers, food additives, and various metal products [1] - It also engages in domestic cargo transportation, import and export of goods, and technology import and export [1] - The company is permitted to conduct business activities autonomously with its business license, excluding projects that require approval [1]

Core Points - The company aims to become a world-class comprehensive solution provider in the chlor-alkali chemical new materials industry, focusing on sustainable development and innovation [4][5] - The registered capital of the company is RMB 819,514,395 [3][21] - The company operates under a governance structure that emphasizes the importance of party leadership and compliance with relevant laws [2][4] Company Structure - The company is established as a joint-stock limited company in accordance with the Company Law of the People's Republic of China [2][3] - The company has a legal representative, either the chairman or the general manager, who is responsible for civil activities conducted in the company's name [3][4] - The company has a board of directors and senior management, which includes the general manager, deputy general managers, financial supervisor, and board secretary [4][5] Business Scope - The company’s business scope includes the production and storage of hazardous chemicals, manufacturing of chemical products, and various technical services [4][5] - The company is committed to upgrading from a single product focus to a comprehensive solution provider, emphasizing digitalization and intelligent operations [4][5] Share Structure - The company has issued a total of 819,514,395 shares, all of which are ordinary shares [21] - The company’s shares are subject to regulations regarding transfer and ownership, ensuring equal rights among shareholders [21][30] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, participate in shareholder meetings, and access company documents [12][34] - Shareholders are obligated to comply with laws and the company’s articles of association, and they cannot withdraw their capital except as legally permitted [41][42] Governance and Decision-Making - The company’s governance structure includes provisions for shareholder meetings, decision-making processes, and the responsibilities of the board of directors [19][22] - Major decisions, such as capital increases or significant asset transactions, require approval from the shareholders [19][33] Compliance and Legal Framework - The company adheres to the Company Law, Securities Law, and other relevant regulations to ensure lawful operations [2][4] - The articles of association serve as a binding document for the company, shareholders, and management, outlining rights and obligations [11][12]

Core Viewpoint - Tianjin Pharmaceutical Co., Ltd. is undergoing significant changes in its operational scope, governance structure, and company charter, which require shareholder approval for implementation [1][2][3]. Summary by Sections Changes in Business Scope - The company plans to expand its business scope to include drug import and export, technology import and export, import and export agency, and goods import and export [2][3]. - The revised business scope includes: - License items: drug production, drug commissioned production, veterinary drug production, cosmetic production, food additive production, feed additive production, hazardous chemical operation, special equipment design, and drug import and export [2][3][4]. - General items: investment activities with self-owned funds, technical services, technical development, technical consulting, technical exchange, technical transfer, technical promotion, traditional Chinese medicine extraction, special chemical product manufacturing (excluding hazardous chemicals), and sales of special chemical products [2][3][4]. Amendments to the Company Charter - The company charter has been revised to align with the Company Law and other relevant regulations, with key changes including: - The first article emphasizes the protection of the rights and interests of the company, shareholders, and creditors [3][4]. - The second article clarifies the founding entities of the company [3][4]. - The eighth article specifies that the general manager is the legal representative of the company, and upon resignation, a new legal representative must be appointed within 30 days [4][5]. - The ninth article introduces provisions regarding the legal consequences of actions taken by the legal representative [4][5]. - The twelfth article outlines the company's operational purpose, focusing on innovation and the integration of high technology and economies of scale [6][7]. Governance Structure Changes - The company will abolish the supervisory board, and the current supervisors will be relieved of their duties upon shareholder approval of the relevant proposals [1][2]. - The company expresses gratitude to the supervisory board and all supervisors for their contributions during their tenure [2][3]. Shareholder Meeting and Approval - The proposed changes will be submitted for approval at the upcoming shareholder meeting, and the current supervisory board will continue to fulfill its supervisory duties until the changes are officially enacted [1][2].